Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates
Callan R. Bleick, Sean R. Van Helden, Andrew David. Berti, Rita Richa, Susan M. Lehman, Arnold S. Bayer, Michael Joseph Rybak
This study evaluates phage-antibiotic combinations against DNS-MRSA strains, finding that simultaneous administration outperforms sequential regimens in ex-vivo models.
Antimicrobial Agents and Chemotherapy · Nov 18, 2025Peer-reviewedMicrobiology